Whether product high quality problems contributed directly to the closure conclusion is not confirmed. But the tests report adds an important dimension into the Peptide Sciences story: the business’s name for reliability was not uniform throughout its entire catalog, notably for more recent plus much more sophisticated compounds. In June 2025,